Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1.

MLA

Goto, Kei, et al. “Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1.” International Journal of Molecular Sciences, vol. 25, no. 9, May 2024, p. 4735. EBSCOhost, https://doi.org/10.3390/ijms25094735.

APA

Goto, K., Fujiwara-Tani, R., Nukaga, S., Miyagawa, Y., Kawahara, I., Nishida, R., Ikemoto, A., Sasaki, R., Ogata, R., Kishi, S., Luo, Y., Fujii, K., Ohmori, H., & Kuniyasu, H. (2024). Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1. International Journal of Molecular Sciences, 25(9), 4735. https://doi.org/10.3390/ijms25094735

Chicago

Goto, Kei, Rina Fujiwara-Tani, Shota Nukaga, Yoshihiro Miyagawa, Isao Kawahara, Ryoichi Nishida, Ayaka Ikemoto, et al. 2024. “Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1.” International Journal of Molecular Sciences 25 (9): 4735. doi:10.3390/ijms25094735.